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Summary: Acquired Immunodeficiency Syndrome (AIDS) is the final and most serious stage of the disease 
caused by human immunodeficiency virus. The Immune system is the target of AIDS. We investigate presently 
any possible involvement of thyroid hormone, the deficiency of which gives rise to oedema and susceptibility to 
nonspecific infections; with a view to finding the primary factor seeding the disease. It has been reported that 
circumcision reduced the incidence of HIV/AIDS infection. Beyond circumcision however there might be some 
constitutional factor that comprises HIV infection to clinical AIDS. It is against this background that our 
research team turned to possible dyshormonopoisis and to thyroid hormone as a prime suspect among other 
possible factors that cause clinical AIDS. Moreover the hormone has been reported to be crucial for optimum 
immune function. A population of 200 seropositive AIDS patients were investigated against a control of 50 
subjects made up of 25 healthy circumcised males and 25 healthy females; all of who were seronegative for the 
disease. The parameters investigated include thyrotropin (TSH), Thyroxine (T4), Total protein (TP), Albumin 
(Alb), Globulin (Glob), Immune complex (IC3) and Bence Jones proteins (BJP) levels in serum or urine.  All 
seropositive clinically HIV/AIDS patients were hypothyroid. Seronegatives had significantly higher T4, TP, and 
Alb levels at P<0.001 and P<0.05 for Glob than seropositives. Seropositive females exhibited significantly 
(P<0.001) higher levels of IC3 than seronegative males. The globulin levels of all HIV patients were 
significantly (P<0.05) higher than control. BJP was also isolated in the urine of patients. The findings suggest 
that thyroid hormone deficiency is a primary culprit for the other inert or dormant factors to be activated. 
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Introduction  
Human immunodeficiency Virus (HIV) infection is 
pandemic World Wide. The scourge is on the 
increase despite attempts by orthodox and herbal 
medical practitioners and scientists to stem it. 
Researches on seropositive patients have shown 
that thrombocytopaenia, and severe anaemia 
manifest as abnormally high erythrocyte 
sedimentation rate (ESR) (Sullivan 2002). It has 
been reported that circumcision reduced the 
incidence of HIV/AIDS infection (World Congress 
on HIV/AIDS 2007).  Beyond circumcision 
however there might be some constitutional factor 
that converts HIV infection to clinical AIDS. It is 
against this background that our research team has 
turned to possible dyshormonopoiesis and to 
thyroid hormone as a prime suspect among other 
possible factors that cause clinical AIDS. 
In an attempt to further elucidate more 
features of HIV disease which erupts as Acquired 
Immunoficiency Sydrome (AIDS) the present study 
was undertaken to investigate any possible 
involvement of thyroid hormone. The finding 
would probably identify its role or status in AIDS 
with a view to attending to the outcome. Thyroid 
hormone was speculated since hypothyroidism 
caused oedema of the uterine tube; which (oedema) 
predisposes the victim to susceptibility to non-
specific infection; HIV infection inclusive (Amadi 
et al, 2007. Moreover the hormone has been 
reported to be crucial for optimal immune function 
(Souba and Smith 1996). 
The study thus aimed to look at the 
thyroid hormone status being a possible primary 
factor that aggravates the disease process in 
HIV/AIDS. The justification for this arose from the 
fact that a number of theories have been put 
forward in attempt to explain variations in the 
development of clinical AIDS after an initial HIV 
infection. These theories include concurrent 
infection with viruses like cytomegalo virus 
(CMV) and hepatitis B-virus infection. This study 
attempts to examine a hormonal state (hypo-
/hyperthyroidism) as a factor that may be linked to 
the development of clinical AIDS with HIV 
infection. The questions that arise from this are 
whether HIV infection can affect thyroid hormone 
formation and/or release? If these were so could it 
have been through direct influence on the gland 
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and/or a primary compromise of its function or 
through another secondary factor? In contrast, 
could it be that the association between the 
hypo/hyperthyroid state and HIV/AIDS was that of 
Hypo/Hyperthyroidism predisposing the individual 
to clinical AIDS?  
Material and methods 
The study was carried out on two hundred 
AIDS patients aged between 20-40 years a sexually 
active age bracket presenting at a leading AIDS 
Clinic (FAITH ALIVE) in Jos. The informed 
consent of the patients and subjects was obtained. 
They were very enthusiastic because of their 
anxiety to seeing if our research findings could lead 
to a cure for their predicament. Fifty (50) volunteer 
healthy subjects who tested negative for HIV or 
AIDS were used as controls. They were matched 
age to age, duration of detected infection and 
gender groups. All the male control and patient 
groups were circumcised in early infancy. Thyroid 
stimulating Hormone (TSH) and free plasma 
thyroxine (T4) Total protein, Albumin Globulin. 
Immune Complex or Complement Fixation and 
Bence Jones proteins were assayed.  
Preparation and examination of blood smear 
  Venous blood samples obtained under 
aseptic conditions were processed for microscopy. 
Thin blood films made from the buffy coat layer 
and from packed red cells respectively of the 
samples anticoagulated in 3.8% Sodium citrate of 
the two groups ie seropositive patients and 
seronegative controls were prepared. The buffy 
coat contains Lymphocytes also known as CD-4 
cells or thymocytes (T cells). (Souba and Smith, 
1996).   They were fixed in absolute methyl 
alcohol for 3 minutes. One volume of Giemsa stain 
solution was diluted with one volume of phosphate 
buffer solution (pH 7.0). The slide was flooded and 
the stain, allowed to stand for 20 minutes. It was 
then washed and differentiated with the phosphate 
buffer solution: drained and dried in air at room 
temperature. The smears were examined for red 
blood cells, and CD-4 cells count by the 
longitudinal and battlement methods of Baker, et 
al, 1994). 
Comparison of immune complex levels 
 Immune complex levels and thus 
complement fixation ability of the two groups were 
determined by the polyethylene Glycol (PEG) 
precipitation according to the method of Haskova 
et al (1978). Each time blood was collected, loss of 
Immune complex by cryroprecipitation was 
avoided by allowing the serum to clot at room 
temperature and determining the immune complex 
immediately; and the blood was collected in a 
siliconized or plastic test tube, allowed to clot over 
one hour, before separating the serum in a 
centrifuge. To 2ml of buffered PEG 6000, 4.166% 
solution was added 0.22ml of serum prediluted 1:3 
with borate buffer. This was properly mixed to 
bring the final concentration of PEG to 3.75% and 
that of serum to1:30. After mixing and incubation 
for 60 mins at room temperature, the light 
absorbance of each test solution was read at 450nm 
against a Blank prepared by adding 0.22ml of 
prediluted serum to 2ml of borate buffer, mixed 
and incubated over the same period.  Its light 
absorbance at 450nm wavelength was measured 
photometrically using 1cm cuvette in a 
spectrophotometer SP6-2000 (PYE UNICAM).  
Low concentrations of PEG (3.7%) were used to 
precipitate soluble antigen-antibody complexes 
while free antigens and antibodies remain in 
solution. 
Standard immune complex calibration curve (fig. 
5) 
Aggregated human gammaglobulin 
(AHG) was used as an in-vitro model (standard) of 
human immune complexes. The AHG was 
prepared by heating native human globulin 1.6% 
(SEVAC. Czechslovakia) in a water bath at 36
0
c 
for 30 mins (Scrimshaw et al 1968; Theofilopoulos 
et al, 1976).  Concentrations of the standard were 
prepared in mg/ml: 80, 40, 20, 10, 5, 2.5. To each 
were added 2.0ml PEG; of standard prediluted 1/3, 
incubated at Room temperature for 1hr and the 
turbidity measured at 450nmλ using 1cm cuvette. 
Total serum protein estimation  
The biuret method of Reinhiold et al 
(1969) was employed. To 0.1ml of test serum was 
added 2.9ml of normal saline and 3.0ml of Biuret 
working solution. For the blank, 3ml of Biuret 
reagent was added to 3.0ml of normal saline. The 
tubes were incubated at 37
0
c in a water bath for 10 
minutes; after which the concentrations were read 
in the spectrophotometer at 540nm and estimated 
from a standard protein calibration curve. The 
serum blanks were read against Tartarate – iodide 
solutions (Rochelle Salt) and the tests and standard 
against the biuret blank. 
Estimation of albumin  
To 4cm
3
 of Bromocresol green (BCG) in a test tube 
was added 0.02cm
3
 of  test serum and mixed. The 
mixture was allowed to stand for 30mins. It was 
then read in the spectrophotometer at 640nm. A 
standard solution containing 3.1g/100ml was 
similarly treated. The albumin contents of the sera 
were calculated. 
Serum globulins  
The differences between the total protein and 
serum albumin was calculated to give total 
globulins (Reinhold, 1969). 
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Bradshaw’s test for bence jones proteins (bjp) 
One ml of urine was layered gently on 4mls of 
concentrated hydrochloric acid in a test tube; 
seropositive and seronegative specimens alike. 
Determination of TSH (µ/ML) 
Thyroid stimulating Hormone (TSH) was assessed 
using the double antibody RIA procedure of Surks, 
et al (1972) as specified by WHO International 
Laboratories (Kits) for Biological Standard 
London; courtesy of Chemical Pathology UCH, 
Ibadan. The kits were purchased locally from 
NUMS Diagnostics which is a subsidiary of UNIS 
Medical Laboratory Diagnostia Centre Ltd. 
Ameritek USA. 
Determination of free thyroixine (t4) (ng/dl) 
The free thyroxine content of all sera was 
determined as applied by Samuels al (1979) using 
RIA reagent Kits. WHO International Laboratories; 
also purchased from Nums Diagnostics.  
Statistical analysis 
Statistical comparisons for unpaired data 
were made by applying the student’s t-test for 
mean, standard deviation and standard error of 
mean on an AMAX computer (Microsoft 
programme).  A probability value of less than 0.05 
was regarded as statistically significant. 
 
Results  
Table 1 is a summary of result obtained.  
Seropositives showed very high thyrotropin levels 
(TSH) but lower thyroxine (T4) at (P<0.001) and 
higher globulin concentration (P<0.05) more than 
seronegatives Immune complex (C3) was 
significantly (P<0.001) higher in seronegative 
males than females. However in females the 
seropositives had higher immune complex than 
seronegatives at the same level of significance. 
Bence Jones Proteins (BJP) was absent (-ve) in 
seronegatives but positive (+ve) in seropositives. 
Blood picture  
Figures 2, 3 & 4 are blood smears of the study 
groups. The red blood cells of seronegative 
controls were robust and fully haemoglobinized 
(figure 2). The Lymphocytes of seropositive-
clinically AIDS patients appears hollow (Ghosts), 
with a mean count of 102±2.8mm
3
. The nuclei 
were split into lobules and eccentrically 
marginalized (Figure 3). The nuclei and cell 
membrane of cD-4 cells of seronegative controls 










Fig. 1: Correlation between soluble immune complex 
levels (mg/ml) and serum total protein levels (g.100ml) 









 Fig. 3: Thymus lymphocytes of seropositive HIV/AIDS 
patient. Giemsa stain. The lymphocytes appear hollow 
(ghost cells). Nuclei of the blood corpuscles split into 
lobules eccentrically marginalized. 
Fig.2: Blood picture of seronegative control. 
Giemsa stain. Red blood cells appear robust and 
fully haemoglobinized. 
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Fontes et al (2003) reported differences in 
mineralocorticoid or thyroid function among 
groups of HIV patients. Ketsamathi et al (2006) 
reported hypothyroidism in some Thai HIV – 
Infected patients and found a few of their studied 
population with subclinical hypothyroidism, 
another fraction had concurrent low T4 and low or 
normal TSH, while a few others had overt 
hyperthyroidism and one with subclinical 
hypothyroidism.   However we found consistent 
hypothyroidism in all the seropositives studied; as 
typified by high thyrotropin (TSH) and low 
thyroxine (T4) levels. Overt hypothyroidism has 
been defined as a high TSH and low T4 levels; 
subclinical hypothyroidism as a high TSH level 
(Betran et al, 2006). 
It has been reported that patients who cannot 
make their own thyroid hormone cannot 
compensate for the reduced thyroid hormone levels 
and hence their thyrotropic hormone level (Judith 
and Harold, 2001). It would thus appear that the 
immune system is in a state of regulatory chaos and 
therefore cannot keep the host alive and healthy 
probably due to reduced sensitivity to thyroid 
hormone or the reduced level. 
The significant depletion of T4 in HIV/AIDS 
patients suggest that hypothyroid state predisposes 
the host cells to nonspecific infection (Amadi et al 
2007); HIV inclusive; by the mechanism of 
transdifferentiation or “Identity deception”. This 
could sustain a different cell line progressively 
depleted of thyroid hormone and vulnerable to viral 
assault. Annarosa et al (2005) had reported stem 
cell transdifferentiation in the adult organism, 
which is capable of generating mature cells beyond 
their own tissue boundaries; although they did not 
explain the causative factor for this phenomenon. 
From the distortion of T-lymphocyte (figure 
3) in hypothyroid seropositives, the hypothyroid 
state could be the pedestal for easy 
transdifferentiation as a result of “stem cell 
deception” from normal euthyroid cells to 
immunodeficient cell readily susceptible to viral 
insult. Identify deception has been documented as a 
non-crime for stem cells (Judith and Harold, 2001) 
Proper levels of thyroxine are reported crucial for 
optimal immune function (Souba and Smith, 1996) 
but hypothyroid state gives rise to a generation of 
cells  resulting in tissues with loose stroma and 
oedema (Amadi et al, 2007). 
Blood specimens showed depressed mean 
cD4- cell population (102±2.8mm-3) for 
seropositive clinically AIDS patients; but normal 
count of the same cells (10,000±8.4mm-3) for 
seronegatives (Table 1), which might be an 
evidence of a gross immune suppression in the 
patients. The T-lymphocytes of the seropositives 
portray deplected “ghost cells” (Fig. 3), which 
appeared polynuclear; depicting hypertrophy of the 
thymus gland. Hypertrophy which is compensatory 
for immunocytes might have lead to 
“neoimmunocytes” producing immunodeficient T. 
cell not immunopotent to the host. Alternatively 
most of the globulins have no antibody activity and 
were globulins but not gamma (γ) globulins or 
antibodies. The high globulin levels in 
hypothyroid seropositives (Table 1) might confirm 
observation by some workers that hyperimmunized 
mice synthesized 5 to 10 times all classes of 
immunoglobulins (Fontes et al 2003). This might 
account for the impaired cell-mediated immunity 
and are thus immunosuppressed.  Low plasma 
albumin and total protein as observed presently 
(fig. 1) have been incriminated as responsible for 
poor lymphocyte transformation; consistent with 
hypothyroidism and presence of BJP found here in 
seropositives. Presence of Bence Jones Proteins 
Fig. 4: Thromocytes of seronegative control. The 
nuclei and cell membrane are intact (Giemsa 
stain). 
Fig. 5: Immune complex aggregating 
gamma globulin standard curve 
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(BJP) implies a degree of dedifferentiation. (Judith 
and Harold, 2001). 
Paradoxically, significantly higher immune 
complex levels were isolated in male seronegative 
while higher values were recorded in female 
seropositives than controls at P<0.001 respectively. 
The low levels suggest that this inactive component 
is being utilized in the activation pathway faster 
than it can be synthesized whereas high C3 level are 
part of the non-specific acute-phase reaction in 
tissue damage. Complement plays an important 
part in body’s defence against infections as a 
mediator of both immune and allergic reactions. 
Invading organism, after identification by 
antibodies, are lysed by activated complement; the 
activation being initiated by the antigen-antibody 
complexes and bacterial liposaccharides or toxins.  
The antibody fixes complement on the surface of 
the invading cells; hence the complement fixation 
test. The level of the complement would indicate 
the relationship between its synthesis and 
utilization in the activation pathway. 
Protein including albumins and globulins are 
indispensable for body defence against infection. 
Protein depletion or its calorie malnutrition 
depresses immune responses of the subjects or have 
other adverse effects (Haskova et al 1978; 
Scrimshaw et al 1968; Theofilopoulos et al, 1976; 
Reinhold, 1969). Starvation or under-nutrition 
impairs immunoglobulin (1g) and serum albumin 
levels; causes diminished mean absolute 
concentrations of total proteins, albumin, α2-
globulins and β-globulins but had little or no 
significant effects on gamma globulin 
concentrations (Surks et al 1972; Samuel et al 
1979). 
However Cooper, et al (1974) reported 
depressed formation of antibodies capable of 
blocking the cytotoxic activity of sensitized 
lymphocytes (Judith and Harold, 2001). There is 
impairment of the antibody formation and 
immunoglobulin levels (Betran et al, 2006); in 
HIV/AIDS patients. 
Bence Jones proteins (BJP) recorded in this 
work on HIV/AIDS patients is found in the urine of 
many patients with malignant immunocytomata. Its 
presence implies a degree of dediffererntiation of 
immunocytes (Judith and Harold,2001). The 
paradox could probably be explained in that either 
the seropositive might not develop enough 
antibodies to form immune complexes as found in 
seronegatives or due to less number of antigenic 
determinants of the complexes and their diminished 
ability to recognize and produce specific antibodies 
against the antigen. The complexes might have 
density less than 19sedberg unit (19S) proteins. 
Complexes of density less than 19S proteins fix 
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 Some workers have shown that the 
antibodies involved in immune complex 
formation are normal divalent molecules 
(Osunkoya, et al., 1972). We have not 
investigated as yet the sex-difference in 
complement fixation.  Could thyroid hormone 
replacement and at what optimum dose and 
period, reverse the decline of immune complex, 
total protein, albumin, globulin and BJP levels in 
HIV/AIDS patients? The findings in the present 
investigation suggest that among other factors, 
thyroid hormone deficiency (hypothyroidism) 
could be a primary culprit in seropositive 
HIV/AIDS disease and that hypothyroid state 
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